| Ytd | 1.65% | |
| 1y | -1.19% |
| Open | 29.42 | Prev Close | 29.35 | Low | 29.33 | High | 29.80 | Mkt Cap | 2.56B |
| Vol | 178.21K | Avg Vol | 1.47M | EPS | -2.01 | P/E | -14.75 | Forward P/E | -105.25 |
| Beta | N/A | Short Ratio | 2.71 | Inst. Own | 84.91% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-13 | 50-d Avg | 28.74 | 200-d Avg | 28.97 | 1yr Est | 36.63 |
HTFL News
Wall Street analysts changed outlook on top names. Check ratings page for upgrades, downgrades, init
After a week of wild swings that rattled portfolios and left investors guessing, Wall Street analyst
The medical technology company reported a notable insider sale in recent filings.
I recommend a buy rating for HeartFlow, Inc. due to its strong clinical workflow integration and exp
Heartflow Plaque Staging TM , the only staging tool based on total plaque volume * , is now included
Heartflow uses artificial intelligence to transform coronary imaging into actionable diagnostic data
Heartflow leverages AI-enabled software to dominate the non-invasive coronary diagnostic market, bac
AI-powered diagnostics meet global oncology innovation as two medical disruptors post strong revenue
In the first quarter of 2026, Baron Discovery Fund declined 10.65% (Institutional Shares), trailing
HeartFlow delivers AI-powered, non-invasive cardiac diagnostics for hospitals and cardiology clinics
Heartflow NASDAQ: HTFL reported a sharply higher first-quarter revenue total and raised its full-yea
HeartFlow, Inc. (HTFL) Q1 2026 Earnings Call Transcript
SAN FRANCISCO, May 14, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the lead
Heartflow and Neptune Insurance deserve a closer look.
Options markets are pricing post-earnings moves between 17.74% and 42.50% on ten small/mid caps repo
HeartFlow provides AI-driven tools for non-invasive heart diagnostics, serving hospitals and clinics
SAN FRANCISCO, April 23, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the le
Heartflow, Inc. (NASDAQ: HTFL - Get Free Report) has received a consensus rating of "Moderate Buy" f
Heartflow asserts that Cleerly infringed foundational patented technology central to the Heartflow P
Heartflow, Inc. (NASDAQ: HTFL - Get Free Report) insider Campbell Rogers sold 64,533 shares of the f
/PRNewswire/ -- USANewsGroup.com News Commentary - Heart disease is a quiet crisis that is draining
HeartFlow's chief medical officer exercised 67,017 options and sold 64,533 Common Stock shares on Ma
U.S. stocks drop, with Dow Jones down 150 points. Signet Jewelers stock rose 11.8% after beating ear